The role of high-intensity focused ultrasound in prostate cancer.
High-intensity focused ultrasound (HIFU) has emerged in the past decade as a new addition to the armamentarium of treatment options for prostate cancer. Clinical studies have investigated its use as a treatment for clinically localized disease and as salvage therapy in the setting of failure after external beam radiotherapy. Additional studies with long-term follow-up are needed to further evaluate the cancer control and quality of life outcomes of this new therapeutic modality.
Lynch
John H
JH
Department of Urology, Georgetown University School of Medicine, NW 4PHC, Washington, DC 20007, USA. lynchj@gunet.georgetown.edu
Loeb
Stacy
S
D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D018084:Ultrasonography, Interventional; D036761:Ultrasound, High-Intensity Focused, Transrectal